>
SyntheticMR AB (publ) logo

SYNT - SyntheticMR AB (publ) Share Price

SEK404 -2.0  -0.5%

Last Trade - 18/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £139.3m
Enterprise Value £138.3m
Revenue £4.14m
Position in Universe 814th / 1828
Bullish
Bearish
Unlock SYNT Revenue
Momentum
Relative Strength (%)
1m -17.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -18.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
6.20 19.0 35.6 48.3 45.8 48.7 79.0 108.5 +51.0%
+2,969 +249.2 +75.3 -74.6 -82.2 +3,050 +70.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2021,SyntheticMR AB revenues increased 17% to SEK14.7M. Netincome applicable to common stockholders increased fromSEK785K to SEK2.7M. Revenues reflect Other Foreign segmentincrease of 20% to SEK14.3M. Net income benefited fromOther external expenses decrease of 13% to SEK5.5M(expense), Other income increase of 25% to SEK1.7M(income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for SYNT
Graphical History

Revenue

SYNT Revenue Unlock SYNT Revenue

Net Income

SYNT Net Income Unlock SYNT Revenue

Normalised EPS

SYNT Normalised EPS Unlock SYNT Revenue

PE Ratio Range

SYNT PE Ratio Range Unlock SYNT Revenue

Dividend Yield Range

SYNT Dividend Yield Range Unlock SYNT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SYNT EPS Forecasts Unlock SYNT Revenue
Profile Summary

SyntheticMR AB (publ) is a Sweden-based company that develops and markets software solutions for Magnetic Resonance Imaging (MRI). The Company provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps, parametric common contrast weighted images and maps of the brain, allowing the investigation to be taken even further. SyMRI is a registered trademark in Europe and in the USA.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since October 18, 2013
No. of Shareholders: n/a
No. of Employees: 24
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange AktieTorget Stock Exchange
Shares in Issue 4,040,078
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SYNT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SYNT
Upcoming Events for SYNT
Thursday 20th May, 2021
SyntheticMR AB (publ) Split For SYNTH.TE - Ratio 10-1
Frequently Asked Questions for SyntheticMR AB (publ)
What is the SyntheticMR AB (publ) share price?

As of 18/05/21, shares in SyntheticMR AB (publ) are trading at SEK404, giving the company a market capitalisation of £139.3m. This share price information is delayed by 15 minutes.

How has the SyntheticMR AB (publ) share price performed this year?

Shares in SyntheticMR AB (publ) are currently trading at SEK404 and the price has moved by 88.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the SyntheticMR AB (publ) price has moved by 47.92% over the past year.

What are the analyst and broker recommendations for SyntheticMR AB (publ)?

There are no analysts currently covering SyntheticMR AB (publ).

When will SyntheticMR AB (publ) next release its financial results?

SyntheticMR AB (publ) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the SyntheticMR AB (publ) dividend yield?

SyntheticMR AB (publ) does not currently pay a dividend.

Does SyntheticMR AB (publ) pay a dividend?

SyntheticMR AB (publ) does not currently pay a dividend.

When does SyntheticMR AB (publ) next pay dividends?

SyntheticMR AB (publ) does not currently pay a dividend.

How do I buy SyntheticMR AB (publ) shares?

To buy shares in SyntheticMR AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of SyntheticMR AB (publ)?

Shares in SyntheticMR AB (publ) are currently trading at SEK404, giving the company a market capitalisation of £139.3m.

Where are SyntheticMR AB (publ) shares listed? Where are SyntheticMR AB (publ) shares listed?

Here are the trading details for SyntheticMR AB (publ):

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: SYNT
What kind of share is SyntheticMR AB (publ)?

Based on an overall assessment of its quality, value and momentum, SyntheticMR AB (publ) is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a SyntheticMR AB (publ) share price forecast 2021?

Shares in SyntheticMR AB (publ) are currently priced at SEK404. At that level they are trading at 6.4% premium to the analyst consensus target price of 0.00.

Analysts covering SyntheticMR AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of 5.17 for the next financial year.

How can I tell whether the SyntheticMR AB (publ) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SyntheticMR AB (publ). Over the past six months, the relative strength of its shares against the market has been 9.06%. At the current price of SEK404, shares in SyntheticMR AB (publ) are trading at 10.54% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the SyntheticMR AB (publ) PE Ratio?

The SyntheticMR AB (publ) PE ratio based on its reported earnings over the past 12 months is 2.47k. The shares are currently trading at SEK404.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of SyntheticMR AB (publ)?

SyntheticMR AB (publ)'s management team is headed by:

Lisa Warnroth - OTH
Jonas Hurtig - DMK
Markus Malmgren - VRD
Staffan Persson - DRC
Johan Sedihn - CHM
Jan Warntjes - DRC
Johanna Noren - CFO
Who are the major shareholders of SyntheticMR AB (publ)?

Here are the top five shareholders of SyntheticMR AB (publ) based on the size of their shareholding:

Handelsbanken Asset Management Investment Advisor/Hedge Fund
Percentage owned: 6.19% (250k shares)
Handelsbanken MicroCap Sverige Mutual Fund
Percentage owned: 6.19% (250k shares)
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 4.95% (200k shares)
Swedbank Robur Microcap Mutual Fund
Percentage owned: 4.95% (200k shares)
Berenberg European Micro Cap Mutual Fund
Percentage owned: 3.58% (145k shares)
Similar to SYNT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.